Actinogen Medical LimitedASX: ACW

ACW webinar on the future of Alzheimers treatment

· Issued by Actinogen Medical Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The event will feature discussions led by the CEO and Chief Commercial Officer, along with expert neurologists. This webinar aims to provide insights into evolving diagnostic and treatment approaches for Alzheimer's disease. Registration details for the event are included in the announcement, which also mentions that a recording will be available afterward.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT Registration details for Actinogen’s August 12 Clinical Trials Science Forum webinar on the future of Alzheimer's treatment Sydney, 5 August 2026. Actinogen Medical ASX: ACW (“ACW” or “the Company”) will host a live Clinical Trials Science Forum webinar at 11am...

Actinogen Medical Limited on 6ix

In the deck

Story so far

Earlier from Actinogen Medical

Later from Actinogen Medical

All Actinogen Medical news releases